Citations

Clear

133 citation(s) found for "Spaulding, A".

Transcutaneous Spinal Cord Stimulation and its Impact on Cardiovascular Autonomic Regulation after Spinal Cord Injury
Tuthill, Christopher, Solinsky, Ryan , Burns, Kathryn , Tuthill, Christopher , Taylor, J Andrew , Solinsky, Ryan , Burns, Kathryn, Tuthill, Christopher, Hamner, Jason W. , Taylor, J. Andrew

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | November 10, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1152/ajpheart.00588.2023 | PMID 37947438 Get It

Individuals with spinal cord injury (SCI) have significant dysfunction in cardiovascular autonomic regulation. While recent findings postulate that spinal cord stimulation improves autonomic regulation, limited scope of past methods have tested only above level sympathetic activation, leaving significant uncertainty. To identify whether transcutaneous spinal cord stimulation improves cardiovascular autonomic regulation, two pairs of well-matched individuals with and without high-thoracic, complete SCI were recruited. Baseline autonomic regulation was characterized with multiple tests of sympathoinhibition and above/below injury level sympathoexcitation. At three subsequent visits, testing was repeated with the addition sub-motor threshold transcutaneous spinal cord stimulation at three previously advocated frequencies. Uninjured controls demonstrated no autonomic deficits at baseline and had no changes with any frequency of stimulation. As expected, individuals with SCI had baseline autonomic dysfunction. In a frequency-dependent manner, spinal cord stimulation enhanced sympathoexcitatory responses, normalizing previously impaired Valsalva's maneuvers. However, stimulation exacerbated already impaired sympathoinhibitory responses, resulting in significantly greater mean arterial pressure increases with the same phenylephrine doses compared to baseline. Impaired sympathoexcitatory response below the level of injury were also further exacerbated with spinal cord stimulation. At baseline, neither individual with SCI demonstrated autonomic dysreflexia with the noxious foot cold pressor test; the addition of stimulation led to a dysreflexic response in every trial, with greater relative hypertension and bradycardia indicating no improvement in cardiovascular autonomic regulation. Collectively, transcutaneous spinal cord stimulation demonstrates no improvements in autonomic regulation after SCI, and instead likely generates tonic sympathoexcitation which may lower the threshold for dangerous autonomic dysreflexia.
Venous Thromboembolism Prophylaxis in Otolaryngologic Patients Using Caprini Assessment
Brennan, Emily , Rutt, Amy L. , Muraleedharan, Divya, Casler, John D., Spaulding, Aaron , Edwards, Michael A. , Rutt, Amy L. , Colibaseanu, Dorin , Spaulding, Aaron

Mayo Clinic

The Laryngoscope | September 23, 2023 | Volume: 134 | Issue: 3 | Pages: 1169-1182

10.1002/lary.31041 | PMID 37740910 Get It

ObjectiveThe aim was to determine the utilization of Caprini guideline‐indicated venous thromboembolism (VTE) prophylaxis and impact on VTE and bleeding outcomes in otolaryngology (ORL) surgery patients.MethodsElective ORL surgeries performed between 2016 and 2021 were retrospectively identified. Logistic regression models were used to examine the association between patient characteristics and receiving appropriate prophylaxis, inpatient, 30‐ and 90‐day VTE and bleeding events.ResultsA total of 4955 elective ORL surgeries were analyzed. Thirty percent of the inpatient cohort and 2% of the discharged cohort received appropriate risk‐stratified VTE prophylaxis. In those who did not receive appropriate prophylaxis, overall inpatient VTE was 3.5‐fold higher (0.73% vs. 0.20%, p = 0.015), and all PE occurred in this cohort (0.47% vs. 0.00%, p = 0.005). All 30‐ and 90‐day discharged VTE events occurred in those not receiving appropriate prophylaxis. Inpatient, 30‐ and 90‐day discharged bleeding rates were 2.10%, 0.13%, and 0.33%, respectively. Although inpatient bleeding was significantly higher in those receiving appropriate prophylaxis, all 30‐ and 90‐day post‐discharge bleeding events occurred in patients not receiving appropriate prophylaxis. On regression analysis, Caprini score was significantly positively associated with likelihood of receiving appropriate inpatient prophylaxis (odds ratio [OR] 1.05, confidence interval [CI] 1.03–1.07) but was negatively associated in the discharge cohort (OR 0.43, CI 0.36–0.51). Receipt of appropriate prophylaxis was associated with reduced odds of inpatient VTE (OR 0.24, CI 0.06–0.69), but not with risk of bleeding.ConclusionAlthough Caprini VTE risk‐stratified prophylaxis has a positive impact in reducing inpatient and post‐discharge VTE, it must be balanced against the risk of inpatient postoperative bleeding.Level of Evidence3 Laryngoscope, 134:1169–1182, 2024
Intravenous tranexamic acid is associated with an increased risk of pulmonary embolism following sarcoma resection
Sebro, Ronnie , Spaulding, Aaron , Goulding, Krista , Houdek, Matthew T. , Wilke, Benjamin K. , Foster, Devon, Garner, Hillary, Stanborough, Rupert, Spaulding, Aaron , Goulding, Krista , Houdek, Matthew T , Wilke, B K , Foster, Devon T. , Garner, Hillary W. , Stanborough, Rupert O.

Mayo Clinic

Journal of Surgical Oncology | July 10, 2023 | Volume: 128 | Issue: 5 | Pages: 869-876

10.1002/jso.27391 | PMID 37428014 Get It

AbstractIntroductionTranexamic acid (TXA) is an antifibrinolytic drug that has been shown to reduce blood loss following surgery. The use of TXA during orthopedic procedures has gained widespread acceptance, with multiple clinical studies demonstrating no increase in thrombotic complications. While TXA has been shown to be safe and effective for several orthopedic procedures, its use in orthopedic sarcoma surgery is not well established. Cancer‐associated thrombosis remains a significant cause of morbidity and mortality in patients with sarcoma. It is unknown if intraoperative TXA use will increase the risk of developing a postoperative thrombotic complication in this population. This study aimed to compare the risk of postoperative thrombotic complications in patients who received TXA during sarcoma resection to patients who did not receive TXA.MethodsA retrospective review was performed of 1099 patients who underwent resection of a soft tissue or bone sarcoma at our institution between 2010 and 2021. Baseline demographics and postoperative outcomes were compared between patients who did and did not receive intraoperative TXA. We evaluated 90‐day complication rates, including: deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), cerebrovascular accident (CVA), and mortality.ResultsTXA was used more commonly for bone tumors (p < 0.001), tumors located in the pelvis (p = 0.004), and larger tumors (p < 0.001). Patients who received intraoperative TXA were associated with a significant increase in developing a postoperative DVT (odds ratio [OR]: 2.22, p = 0.036) and PE (OR: 4.62, p < 0.001), but had no increase in CVA, MI, or mortality (all p > 0.05) within 90 days of surgery, following univariate analysis. Multivariable analysis confirmed that TXA was independently associated with developing a postoperative PE (OR: 10.64, 95% confidence interval: 2.23–50.86, p = 0.003). We found no association with DVT, MI, CVA, or mortality within 90 days postoperatively, following intraoperative TXA use.ConclusionOur results demonstrate a higher associated risk of PE following TXA use in sarcoma surgery and caution is warranted with TXA use in this patient population.
Effectiveness of care models for chronic disease management: A scoping review of systematic reviews
Kroenke, Kurt , Ralston, Rick , Zafonte, Ross , Brunner, Robert, Hoffman, Jeanne M. , Esterov, Dmitry , Mellick, David C., Scott, Steven , Zafonte, Ross , Bell, Kathleen , Hammond, Flora M , Corrigan, John D. , Giacino, Joseph T. , Cifu, David X. , Bell, Kathleen , Sander, Angelle M. , Hammond, Flora M.

Mayo Clinic

PM&R | June 17, 2023 | Volume: 16 | Issue: 2 | Pages: 174-189

10.1002/pmrj.13027 | PMID 37329557 Get It

Abstract Objective To conduct a scoping review of models of care for chronic disease management to identify potentially effective components for management of chronic traumatic brain injury (TBI). Methods Information sources : Systematic searches of three databases (Ovid MEDLINE, Embase, and Cochrane Database of Systematic Reviews) from January 2010 to May 2021. Eligibility criteria : Systematic reviews and meta‐analyses reporting on the effectiveness of the Chronic Care Model (CCM), collaborative/integrated care, and other chronic disease management models. Data : Target diseases, model components used ( n = 11), and six outcomes (disease‐specific, generic health‐related quality of life and functioning, adherence, health knowledge, patient satisfaction, and cost/health care use). Synthesis : Narrative synthesis, including proportion of reviews documenting outcome benefits. Results More than half (55%) of the 186 eligible reviews focused on collaborative/integrated care models, with 25% focusing on CCM and 20% focusing on other chronic disease management models. The most common health conditions were diabetes ( n = 22), depression ( n = 16), heart disease ( n = 12), aging ( n = 11), and kidney disease ( n = 8). Other single medical conditions were the focus of 22 reviews, multiple medical conditions of 59 reviews, and other or mixed mental health/behavioral conditions of 20 reviews. Some type of quality rating for individual studies was conducted in 126 (68%) of the reviews. Of reviews that assessed particular outcomes, 80% reported disease‐specific benefits, and 57% to 72% reported benefits for the other five types of outcomes. Outcomes did not differ by the model category, number or type of components, or target disease. Conclusions Although there is a paucity of evidence for TBI per se, care model components proven effective for other chronic diseases may be adaptable for chronic TBI care.
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease—time for universal recommendation? Authors' reply
Caldera, Freddy , Spaulding, Aaron , Spaulding, Aaron C. , Spaulding, Aaron , Caldera, Freddy , Hayney, Mary S. , Farraye, Francis A.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | May 11, 2023 | Volume: 57 | Issue: 11 | Pages: 1345-1346

10.1111/apt.17519 | PMID 37161632 Get It

LINKED CONTENTThis article is linked to Caldera et al papers. To view these articles, visit https://doi.org/10.1111/apt.17454 and https://doi.org/10.1111/apt.17490
Cost‐effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease
Caldera, Freddy , Spaulding, Aaron , Moriarty, Jim, Zhu, Ye , Spaulding, Aaron C. , Spaulding, Aaron , Caldera, Freddy , Borah, Bijan J. , Hayney, Mary S. , Farraye, Francis A.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | March 10, 2023 | Volume: 57 | Issue: 11 | Pages: 1326-1334

10.1111/apt.17454 | PMID 36896952 Get It

Summary Background Recombinant zoster vaccine (RZV) is recommended for all adults ≥19 years of age who are at increased risk for HZ, including patients with inflammatory bowel disease (IBD). Methods A Markov model was constructed to compare the RZV cost‐effectiveness with no vaccination in patients with Crohn's Disease (CD) and ulcerative colitis (UC). A simulated cohort of 1 million patients was used for each IBD group at ages 18, 30, 40, and 50. The primary objective of this analysis was to compare RZV cost‐effectiveness in patients with CD and UC, comparing vaccination to no vaccination. Results Overall, vaccination is cost‐effective for both CD and UC, with the incremental cost‐effectiveness ratio (ICERs) below $100,000/quality‐adjusted life years (QALY) for all age cohorts. For patients with CD, 30 years of age and older, and those with UC 40 years and older, vaccination was both more effective and less expensive than the non‐vaccinated strategy (CD ≥30: ICERs $6183–$24,878 and UC ≥40: ICERs $9163–$19,655). However, for CD patients under 30 (CD 18: ICER $2098) and UC patients under 40 (UC = 18: ICER $11,609, and UC = 30: $1343), costs were greater for vaccinated patients, but there was an increase in QALY. One‐way sensitivity analysis of age indicates that cost break‐even occurs at age 21.8 for the CD group and 31.5 for the UC group. In probabilistic sensitivity analysis, 92% of both CD and UC simulations indicated that vaccination was preferred. Conclusion In our model, vaccination with RZV was cost‐effective for all adult patients with IBD.
Improving Health and Addressing Social Determinants of Health Through Hospital Partnerships
Hamadi, Hanadi , Zhao, Mei , Park, Sinyoung , Xu, Jing , Haley, D. Rob , Lox, Curt , Spaulding, Aaron , Hamadi, Hanadi Y , Haley, Donald Rob , Spaulding, Aaron , Zhao, Mei

Mayo Clinic

Population Health Management | March 1, 2023 | Volume: 26 | Issue: 2 | Pages: 121-127

10.1089/pop.2023.0002 | PMID 36856461 Get It

Hospitals and health systems are forming partnerships to develop an integrated social network of services that better address the needs of their surrounding communities and their social determinants of health (SDOH). There is little research on the association of these partnered services with hospital outcomes. This study examined the association between hospital social need partnerships and activities to improve hospital and community outcomes. A secondary cross-sectional design to analyze 2021 census data of nonfederal short-term acute care hospitals in the United States was utilized. Data were obtained from the American Hospital Association. Four multilevel logistic regression models were used to analyze data from 1005 hospitals. The authors found that hospital partnership type differed in association to social need outcomes. They found that hospitals with a partnership with health insurance providers were more likely to have better health outcomes. Hospitals partnered with health insurance providers, local organizations addressing housing insecurity, local businesses, or chambers of commerce were more likely to have decreased health care costs. Hospitals partnered with health care providers, health insurance providers, local organizations providing legal assistance, or law enforcement/safety forces were more likely to have decreased utilization of hospital services. However, hospitals partnered with other local or state government or social service organizations were less likely to indicate decreased utilization of services. Many hospitals and health systems across the United States are screening for SDOH and are advancing health care delivery and improving the community's overall health and well-being by identifying unmet social needs and partnering with the community to address them.
Demographic Characteristics Influence Treatment Costs of Invasive Melanoma in Florida
Spaulding, Aaron , Rinker, Brian, Huayllani, María T. , Maita, Karla C. , Ho, Olivia A. , Spaulding, Aaron C. , Torres-Guzman, Ricardo A, Spaulding, Aaron , Ávila, Francisco R. , Boczar, Daniel , Torres‐Guzman, Ricardo A. , Forte, Antonio J.

Mayo Clinic

Annals of Plastic Surgery | February 16, 2023 | Volume: 90 | Issue: 3 | Pages: 248-254

10.1097/sap.0000000000003422 | PMID 36796047 Get It

Background Demographic characteristics are known to influence the treatment and outcomes of patients with invasive melanoma. Whether these characteristics influence treatment costs is unknown. We aimed to analyze whether patient demographics and tumor characteristics influence treatment costs for patients with invasive cutaneous melanoma in Florida. Methods This was a cross-sectional study in which the Florida Inpatient and Outpatient Dataset of the Agency for Health Care Administration was analyzed for patients with a diagnosis of invasive melanoma between January 1, 2013 and December 31, 2018. Categorical variables were assessed using Pearson χ2 tests, and continuous variables were evaluated using Kruskal-Wallis tests. Logistic regression analysis was conducted to identify the association between patient demographics and total costs. All analyses were done using SAS 9.4 statistical software (SAS Institute, Inc). Results Multivariate analysis showed that sex (P < 0.001), hospital setting (P < 0.001), race/ethnicity (P < 0.01), patient region (P < 0.01), Elixhauser Comorbidity Index score (P < 0.001), presence of metastasis (P < 0.01), total number of procedures (P < 0.001), and length of stay (P < 0.001) were correlated with the cost of treatment of invasive cutaneous melanoma. After stratification, the association between cost and race/ethnicity disappeared for inpatients but remained for Black patients in the outpatient setting (P < 0.001). The association between cost and patient residence regions also differed when the cohort was stratified. Conclusions Strategies addressing disparities in treatment cost of invasive melanoma should differ, depending on the hospital setting where the patient is being treated.
Improved needs identification in medical intensive care and palliative medicine: retrospective cohort study
Rossnan, Olivia, Hanson, Abby , Spaulding, Aaron , SATASHIA, PARTHKUMAR , Bhakta, Shivang , Robinson, Maisha T. , Helgeson, Scott A. , Sanghavi, Devang , Robinson, Maisha, Moreno-Franco, Pablo, Spaulding, Aaron , Helgeson, Scott A , Franco, Pablo Moreno

Mayo Clinic

BMJ Supportive & Palliative Care | February 16, 2023 | Volume: 14 | Issue: e1 | Pages: e330-e331

10.1136/spcare-2023-004205 | PMID 36797044 Get It

COVID-19 Deaths and the Impact of Health Disparities, Hospital Characteristics, Community, Social Distancing, and Health System Competition
Zhao, Mei , Hamadi, Hanadi , Haley, D. Rob , Xu, Jing , Tafili, Aurora , Spaulding, Aaron , Hamadi, Hanadi Y , Spaulding, Aaron , Haley, Donald Rob , Zhao, Mei

Mayo Clinic

Population Health Management | December 28, 2022 | Volume: 25 | Issue: 6 | Pages: 807-813

10.1089/pop.2022.0144 | PMID 36576382 Get It

The United States has one of the highest cumulative mortalities of coronavirus disease 2019 (COVID-19) and has reached 1 million deaths as of May 19th, 2022. Understanding which community and hospital factors contributed to disparities in COVID-19 mortality is important to inform public health strategies. This study aimed to explore the potential relationship between hospital service area (1) community (ie, health professional shortage areas, market competition, and uninsured percentage) and (2) hospital (ie, teaching, system, and ownership status) characteristics (2013–2018) on publicly available COVD-19 (February to October 2020) mortality data. The study included 2514 health service areas and used multilevel mixed-effects linear model to account for the multilevel data structure. The outcome measure was the number of COVID-19 deaths. This study found that public health, as opposed to acute care provision, was associated with community health and, ultimately, COVID-19 mortality. The study found that population characteristics including more uninsured greater proportion of those over 65 years, more diverse populations, and larger populations were all associated with a higher rate of death. In addition, communities with fewer hospitals were associated with a lower rate of death. When considering region in the United States, the west region showed a higher rate of death than all other regions. The association between some community characteristics and higher COVID-19 deaths demonstrated that access to health care, either for COVID-19 infection or worse health from higher disease burden, is strongly associated with COVID-19 deaths. Thus, to be better prepared for potential future pandemics, a greater emphasis on public health infrastructure is needed.